Merck begins hunt for new CEO
The drugmaker is scouting for a replacement for its CEO, Kenneth Frazier.
Sun Pharma hit with Form 483 for Halol facility
The drugmaker said it has received four observations from the U.S. FDA for its Halol facility in Gujarat.
The drugmaker said it has received four observations from the U.S. FDA for its Halol facility in Gujarat.
FDA rejects Daiichi Sankyo's blood cancer treatment
Just days after receiving approval in Japan, Daiichi Sankyo said the U.S. FDA will not approve its drug, quizartinib.
Pharma's budding opportunity
Why the industry is forming bonds with CBD
Report: Pfizer passed on promising Alzheimer's research
The drugmaker admitted that studies showed its rheumatoid arthritis medication Enbrel could potentially reduce the risk of Alzheimer’s by 64 percent.